Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity - PubMed (original) (raw)

. 1993 Aug 19;364(6439):725-9.

doi: 10.1038/364725a0.

Affiliations

• PMID: 8355788
• DOI: 10.1038/364725a0

Free article

Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity

G A Cox et al. Nature. 1993.

Free article

Abstract

Duchenne and Becker muscular dystrophy (DMD and BMD) are X-linked recessive diseases caused by defective expression of dystrophin. The mdx mouse, an animal model for DMD, has a mutation that eliminates expression of the 427K muscle and brain isoforms of dystrophin. Although these animals do not display overt muscle weakness or impaired movement, the diaphragm muscle of the mdx mouse is severely affected and shows progressive myofibre degeneration and fibrosis which closely resembles the human disease. Here we explore the feasibility of gene therapy for DMD by examining the potential of a full-length dystrophin transgene to correct dystrophic symptoms in mdx mice. We find that expression of dystrophin in muscles of transgenic mdx mice eliminates the morphological and immunohistological symptoms of muscular dystrophy. In addition, overexpression of dystrophin prevents the development of the abnormal mechanical properties associated with dystrophic muscle without causing deleterious side effects. Our results provide functional evidence for the feasibility of gene therapy for DMD.

PubMed Disclaimer

Comment in

• Muscular dystrophy. Muscling in on gene therapy.
  Blau HM. Blau HM. Nature. 1993 Aug 19;364(6439):673-5. doi: 10.1038/364673a0. Nature. 1993. PMID: 8355780 No abstract available.

Similar articles

• Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.
  Tinsley JM, Potter AC, Phelps SR, Fisher R, Trickett JI, Davies KE. Tinsley JM, et al. Nature. 1996 Nov 28;384(6607):349-53. doi: 10.1038/384349a0. Nature. 1996. PMID: 8934518
• Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
  Ito K, Kimura S, Ozasa S, Matsukura M, Ikezawa M, Yoshioka K, Ueno H, Suzuki M, Araki K, Yamamura K, Miwa T, Dickson G, Thomas GD, Miike T. Ito K, et al. Hum Mol Genet. 2006 Jul 15;15(14):2266-75. doi: 10.1093/hmg/ddl151. Epub 2006 Jun 15. Hum Mol Genet. 2006. PMID: 16777842
• Mini-dystrophin gene transfer in mdx4cv diaphragm muscle fibers increases sarcolemmal stability.
  Decrouy A, Renaud JM, Davis HL, Lunde JA, Dickson G, Jasmin BJ. Decrouy A, et al. Gene Ther. 1997 May;4(5):401-8. doi: 10.1038/sj.gt.3300407. Gene Ther. 1997. PMID: 9274716
• [Current status and perspective of gene therapy on dystrophic animal model].
  Takeda S. Takeda S. Rinsho Shinkeigaku. 2004 Nov;44(11):911-3. Rinsho Shinkeigaku. 2004. PMID: 15651329 Review. Japanese.
• [Development of new therapy on muscular dystrophy].
  Takeda S. Takeda S. Rinsho Shinkeigaku. 2001 Dec;41(12):1154-6. Rinsho Shinkeigaku. 2001. PMID: 12235824 Review. Japanese.

Cited by

• Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation.
  Frock RL, Kudlow BA, Evans AM, Jameson SA, Hauschka SD, Kennedy BK. Frock RL, et al. Genes Dev. 2006 Feb 15;20(4):486-500. doi: 10.1101/gad.1364906. Genes Dev. 2006. PMID: 16481476 Free PMC article.
• Differentiation and fiber type-specific activity of a muscle creatine kinase intronic enhancer.
  Tai PW, Fisher-Aylor KI, Himeda CL, Smith CL, Mackenzie AP, Helterline DL, Angello JC, Welikson RE, Wold BJ, Hauschka SD. Tai PW, et al. Skelet Muscle. 2011 Jul 7;1:25. doi: 10.1186/2044-5040-1-25. Skelet Muscle. 2011. PMID: 21797989 Free PMC article.
• Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.
  Amalfitano A, Hauser MA, Hu H, Serra D, Begy CR, Chamberlain JS. Amalfitano A, et al. J Virol. 1998 Feb;72(2):926-33. doi: 10.1128/JVI.72.2.926-933.1998. J Virol. 1998. PMID: 9444984 Free PMC article.
• Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies.
  Lim KRQ, Sheri N, Nguyen Q, Yokota T. Lim KRQ, et al. Genes (Basel). 2020 Jul 8;11(7):765. doi: 10.3390/genes11070765. Genes (Basel). 2020. PMID: 32650403 Free PMC article. Review.
• Human cytomegalovirus IE1 promoter/enhancer drives variable gene expression in all fiber types in transgenic mouse skeletal muscle.
  Hallauer PL, Hastings KE. Hallauer PL, et al. BMC Genet. 2000;1:1. doi: 10.1186/1471-2156-1-1. Epub 2000 Oct 4. BMC Genet. 2000. PMID: 11038264 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • MLibrary (Deep Blue)
  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Research Materials

  • Addgene Non-profit plasmid repository